FIELD: medicine. SUBSTANCE: means is polyfunctional preparation having two biologically active ingredients: purified liquid cattle prostate extract concentrate and an ingredient having human α- interferon activity being purified liquid condensed leukocyte α-interferon or recombinant α-interferon with stabilizer and filler in the amount enough for producing suppository. EFFECT: enhanced effectiveness of treatment in cases accompanied by immune deficiency. 5 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RECTAL AGENT | 1999 |
|
RU2152204C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
| PREPARATION FOR TREATMENT OF PROSTATIC GLAND DISEASES MADE IN FORM OF A SUPPOSITORY | 2019 |
|
RU2752588C2 |
| MEANS FOR TREATMENT OF CHRONIC PROSTATITIS | 2007 |
|
RU2342940C1 |
| METHOD FOR TREATING PROSTATIC DISEASES | 2005 |
|
RU2304979C2 |
| AGENT "VITAPROST" FOR PROSTATE GLAND DISEASE TREATMENT | 1996 |
|
RU2112504C1 |
| BIOLOGICALLY ACTIVE PHOSPHOLIPID-COMPRISING COMPLEX FOR TREATMENT OF PSORIASIS AND CHRONIC PROSTATITIS | 2003 |
|
RU2275205C2 |
| METHOD FOR DETECTING BIOLOGICAL ACTIVITY OF PREPARATIONS MADE OF PROSTATIC TISSUE | 2000 |
|
RU2186387C2 |
| RECTAL SUPPOSITORIES FOR PROSTATE TREATMENT CONTAINING LYSYL-GLUTAMYL-ASPARTYL-PROLINE TETRAPEPTIDE | 2017 |
|
RU2640931C1 |
